DEVELOPMENT OF THERANOSTIC FERUMOXIDE AND GADOLINIUM NANOLIPOSOMES FOR CONTROLLED RELEASE OF CYTOKINES

1,3 SKOPALÍK Josef
Co-authors:
1 PRŮCHA Jaroslav 3 PARÁK Tomáš 2 ČMIEL Vratislav 2 SEKORA Jiří
Institutions:
1 Faculty of Biomedical Engineering, Czech Technical University in Prague, Czech Republic, EU, skopajos@fbmi.cvut.cz
2 Faculty of Electrical Engineering and Communication, Brno University of Technology, Brno, Czech Republic, EU
3 Faculty of Pharmacy, Masaryk University, Brno, Czech Republic, EU
Conference:
16th International Conference on Nanomaterials - Research & Application, OREA Congress Hotel Brno, Czech Republic, EU, October 16 - 18, 2024
Proceedings:
Proceedings 16th International Conference on Nanomaterials - Research & Application
Pages:
266-270
ISBN:
978-80-88365-24-2
ISSN:
2694-930X
Published:
28th February 2025
Metrics:
31 views / 15 downloads
Abstract

Several experimental strategies have been formulated to develop theranostic liposomes by incorporating both drugs and various imaging contrast agents.in last decades. Liposome kinetics and cracking could be potentiated by external forces (ultrasound, electro-magnetic, laser induced). Gadolinium is used in many contrast entities, and they could be detectable by various methods of electron microscopy and tomography if the concentration is within a good range of values. Our workplace is working with a wide range of extracellular vesicles, which are natural transporters of regenerative factors. In order to evaluate the Gd-label effectiveness for some specific extracellular vesicles (specific exosomes derived from mesenchymal stromal cells), experimental labeling methods were prepared. We prepared original conjugation methods for Gd-DSPS binding to the surface lipid layer of extracellular vesicles, and evaluation by electron microscopy and DLS methods was conducted. To reveal possible adverse effects of Gd-vesicles that may be initiated after contact with living cells, we also evaluated basic cytotoxicity tests, and we conducted a statistical survey for metal distribution from dermal dressing into different tissues. Results of tests revealed that vesicles before and after Gd-labeling had very similar sizes (115 versus 122 nm) and similar zeta potential. It has been demonstrated that Gd-vesicles are stable particles in the dermis and subdermal region, still detectable after 12 days as compact nanobodies with high contrast under electron microscopy in dermal tissue. A simple dose of 20 µg per 1 cm² on dermal tissue (mixed in a hydrogel drop) showed very good diffusion into the tissues over the next 6 days. The diffused concentration of vesicles is sufficient for the quantification of particles with mass spectrometry after taking a biopsy, but not yet sufficient for the quantification of particles by traditional X-ray or MRI tomography. Gd-release had no adverse toxicity. A modified variant, “Gd + extra sono-stimul,” was evaluated at the end of the experiment. There is evidence that sono-stimulation could accelerate the penetration of healing vesicles into the target dermal tissue.

Keywords: Nanovesicles, metal toxicity, medical device, tissue model, liposome kinetic

© This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Scroll to Top